To date, the device has not been returned.
If the product is returned for evaluation, any further information derived from the evaluation will be submitted in a supplemental 3500a form.
(b)(4) submitted for adverse event which occurred on (b)(6) 2019.
(b)(4) submitted for adverse event which occurred on (b)(6) 2020.
|
It was reported by an attorney that the patient underwent a gynecological surgical procedure on (b)(6) 2012 and two (2) mesh products were implanted, due to pelvic organ prolapse and urinary incontinence.
It was reported that the patient experienced recurrent urinary incontinence, vaginal bleeding, inflamed cervix, recurrent urinary tract infections, dyspareunia, chronic pain, foul smelling discharge, erosion of the mesh into her vaginal wall, and erosion of the other mesh into her cervix and adherence to her bowel.
It was reported that the patient underwent surgical procedures on (b)(6) 2019 and (b)(6) 2020 to remove the products.
No additional information was provided.
|